Heribert Ramroth

Chapel Hill
Buenos Aires, C, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Timing of Remdesivir Initiation and Clinical Outcomes in Hospitalized Patients with COVID-19 Who Are at High Risk of Disease Progression in Japan: A Health Insurance Claims Database Study.

Timing of Remdesivir Initiation and Clinical Outcomes in Hospitalized Patients with COVID-19 Who Are at High Risk of Disease Progression in Japan: A Health Insurance Claims Database Study.

Journal: Viruses

Published: February 12, 2026

Real-world effectiveness of remdesivir in immunocompromised patients hospitalized due to SARS-CoV-2 Infection: Insights to inform pharmacy practice.

Real-world effectiveness of remdesivir in immunocompromised patients hospitalized due to SARS-CoV-2 Infection: Insights to inform pharmacy practice.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Published: February 10, 2026

Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium.

Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium.

Journal: International journal of cancer

Published: November 26, 2025

A practical evaluation of statistical methods for the analysis of patient reported outcomes in an observational pharmaceutical study.

A practical evaluation of statistical methods for the analysis of patient reported outcomes in an observational pharmaceutical study.

Journal: PloS one

Published: October 11, 2024

Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study.

Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study.

Journal: HIV medicine

Published: April 12, 2024

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.

Journal: Viruses

Published: September 27, 2022

Larynx preservation up to T4 laryngeal cancer?

Larynx preservation up to T4 laryngeal cancer?

Journal: HNO

Published: April 07, 2022

Larynx preservation: recommendations for decision-making in T3 laryngeal cancer patients

Larynx preservation: recommendations for decision-making in T3 laryngeal cancer patients

Journal: HNO

Published: March 17, 2022

Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany.

Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 01, 2022

Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.

Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.

Journal: Alimentary pharmacology & therapeutics

Published: September 24, 2021

Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium.

Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium.

Journal: Oral diseases

Published: September 10, 2021

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.

Journal: Alimentary pharmacology & therapeutics

Published: August 11, 2021

Showing 1-12 of 45

Last Updated: 09/26/2026